Anticancer drug company: Eagle Pharmaceuticals (EGRX) (2007)

Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) was founded in 2007 and is headquartered in Woodcliff Lake, New Jersey, USA, with 96 full-time employees. It is a professional pharmaceutical company dedicated to the development and commercialization of intensive care and oncology in the United States. Field of injection products.

Eagle Pharmaceuticals EGRX Logo

Eagle Pharmaceuticals (EGRX):

Eagle Pharmaceuticals is a professional pharmaceutical company in the United States dedicated to the development of injectable drugs for critically ill patients and cancer patients. The company’s main products are:

  • Argatroban-used to treat heparin-induced thrombocytopenia;
  • Ryanodex injection suspension-used to treat malignant high fever;
  • EP-3101 and EP-3102 injection-is a RTD (ready to dilute) injection, used to treat chronic lymphocytic leukemia and painless non-Hodgkin’s lymphoma;
  • EP-4104-For the treatment of heat stroke;
  • EP-5101 (Pemetrexed)-an RTD injection for the treatment of lung cancer and mesothelioma, currently in the preclinical stage;
  • EP-6101-For percutaneous transluminal angioplasty (percutaneous transluminal angioplasty)-Refer to Wikipedia .

Eagle Pharmaceuticals (EGRX) investment:

Market rumors: Teva Pharmaceuticals is said to have shown a strong interest in Eagle Pharmaceuticals after the failed acquisition of Mylan . Similar anti-cancer drug companies include: KITE , JUNO , ADRO , ADXS , BLCM , BLUE, etc.

Notify of
Inline Feedbacks
View all Intels

Well-known retail chain in the United States: Dollar General (DG) (1939)

China Stocks: Dangdang (DANG) (1999)